SPECIAL COMMENTARIESHealthcare disparities in telemedicine for rheumatology careJackson, Lesley E.; Danila, Maria I. Author Information Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA Correspondence to Maria I. Danila, MD, MSc, MSPH, University of Alabama at Birmingham, 1720 Second Ave South, FOT 838, Birmingham, AL 35294, USA. Tel: +1 205 996 5602; fax: +1 205 934 4198; e-mail: [email protected] Current Opinion in Rheumatology: May 2022 - Volume 34 - Issue 3 - p 171-178 doi: 10.1097/BOR.0000000000000869 Buy Metrics Abstract Purpose of review We summarize the recent literature published in the last 2 years on healthcare disparities observed in the delivery of rheumatology care by telemedicine. We highlight recent research dissecting the underpinnings of healthcare disparities and identify potentially modifiable contributing factors. Recent findings The COVID-19 pandemic has had major impacts on care delivery and has led to a pronounced increase in telemedicine use in rheumatology practice. Telemedicine services are disproportionately underutilized by racial/ethnic minority groups and among patients with lower socioeconomic status. Disparities in telemedicine access and use among vulnerable populations threatens to exacerbate existing outcome inequalities affecting people with rheumatic disease. Summary Telemedicine has the potential to expand rheumatology services by reaching traditionally underserved communities. However, some areas lack the infrastructure and technology to engage in telemedicine. Addressing health equity and the digital divide may help foster more inclusive telemedicine care. Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.